Here's a Biotech IPO You Don’t Want To Miss
You might be too busy to pay much attention to every tiny biotech that goes public. There's one initial public offering (IPO) coming up, though, that I think you'll want to keep your eyes on. Jounce Therapeutics filed a few days ago for an IPO in 2017. Any company that Celgene (NASDAQ:CELG) is willing to invest in big-time is one that is worth watching.